Trial Details

TERMINATED
Basic Information
Clinical ID c4177
Identifier NCT00932841
Trial Title The Use of VSL#3 in Irritable Bowel Syndrome in Children
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome
Interventions OTHER: Placebo|DRUG: VSL#3 900 billion bacteria|DRUG: VSL#3 90 billion bacteria
Participant Information
Sponsor Dayton Children's Hospital
City Dayton
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2008-01
Primary Completion Date 2011-08
Completion Date 2011-08